ABIOMED Performance
The firm shows a Beta (market volatility) of -0.0211, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ABIOMED are expected to decrease at a much lower rate. During the bear market, ABIOMED is likely to outperform the market. ABIOMED at this moment shows a risk of 0.0%. Please confirm ABIOMED variance and the relationship between the treynor ratio and expected short fall , to decide if ABIOMED will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ABIOMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, ABIOMED is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 232.7 M | |
| Total Cashflows From Investing Activities | -381 M |
ABIOMED |
ABIOMED Relative Risk vs. Return Landscape
If you would invest (100.00) in ABIOMED on September 12, 2024 and sell it today you would earn a total of 100.00 from holding ABIOMED or generate -100.0% return on investment over 90 days. ABIOMED is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ABIOMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ABIOMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABIOMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ABIOMED, and traders can use it to determine the average amount a ABIOMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ABMD |
Based on monthly moving average ABIOMED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABIOMED by adding ABIOMED to a well-diversified portfolio.
ABIOMED Fundamentals Growth
ABIOMED Stock prices reflect investors' perceptions of the future prospects and financial health of ABIOMED, and ABIOMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABIOMED Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Price To Earning | 76.38 X | |||
| Price To Book | 11.13 X | |||
| Price To Sales | 15.96 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 268.49 M | |||
| Cash And Equivalents | 844.32 M | |||
| Cash Per Share | 18.57 X | |||
| Total Debt | 10 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 34.09 X | |||
| Cash Flow From Operations | 285.39 M | |||
| Earnings Per Share | 5.83 X | |||
| Total Asset | 1.67 B | |||
| Retained Earnings | 650.05 M | |||
| Current Asset | 288.39 M | |||
| Current Liabilities | 46.54 M | |||
About ABIOMED Performance
By analyzing ABIOMED's fundamental ratios, stakeholders can gain valuable insights into ABIOMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ABIOMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ABIOMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.Things to note about ABIOMED performance evaluation
Checking the ongoing alerts about ABIOMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ABIOMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ABIOMED is not yet fully synchronised with the market data | |
| ABIOMED has some characteristics of a very speculative penny stock | |
| ABIOMED has a very high chance of going through financial distress in the upcoming years | |
| Over 97.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ABIOMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABIOMED's stock is overvalued or undervalued compared to its peers.
- Examining ABIOMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABIOMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABIOMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ABIOMED's stock. These opinions can provide insight into ABIOMED's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world |